Sepsis in mice stimulates muscle proteolysis in the absence of IL-6

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Williams, Arthur ^a   Wang, Jing Jing ^a   Wang, L I ^a   Sun, Xiaoyan ^a   Fischer, Josef E ^a   Hasselgren, Per Olof ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Interleukin 6 knockout mice; Myofibrillar proteins; Myotubes; Protein breakdown; Ubiquitin

Indexed keywords

CYTOKINE; MESSENGER RNA; MUSCLE PROTEIN; RECOMBINANT INTERLEUKIN 6; UBIQUITIN;

ANIMAL MODEL; ARTICLE; CATABOLISM; CONTROLLED STUDY; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SEPSIS; SKELETAL MUSCLE;

EID: 0032430097     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.275.6.r1983     Document Type: Article

References (40)

1. Chomczynski, P., and N. Sacchi. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
2. Ciechanover, A. The ubiquitin-proteasome pathway. Cell 79: 13-21, 1994.
3. Clowes, G. H. A., B. C. George, C. A. Villee, and C. A. Saravis. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N. Engl. J. Med. 308: 545-552, 1983.
4. Ebisui, C., T. Tsujinaka, T. Morimoto, K. Kan, S. Ilijima, M. Yano, E. Kominami, K. Tanaka, and M. Monden. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. (Colch.) 89: 431-439, 1995.
5. Espat, N. J., T. Auffenberg, J. J. Rosenberg, M. Rogy, D. Martin, C. H. Fang, P. O. Hasseigren, E. M. Copeland, and L. L. Moldawer. Ciliary neurotrophic factor is catabolic and shares with IL-6 the cap'acity to induce an acute phase response. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R185-R190, 1996.
6. Fang, C. H., G. Tiao, J. H. James, C. K. Ogle, J. E. Fischer, and P. O. Hasselgren. Burn injury stimulates multiple proteolytic pathways in skeletal muscle including the ubiquitin-energy-dependent pathway. J. Am. Coll. Surg. 180: 161-170, 1995.
7. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Glezzi, and V. Poli. Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180: 1243-1250, 1994.
8. Garcia-Martinez, C., F. J. Lopez-Soriano, and J. M. Argiles. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett. 76:1-4, 1994.
9. Gauldie, J., C. Richards, and H. Baumann. IL-6 and the acute phase reaction. Res. Immunol. 143: 755-759, 1992.
10. Goldberg, A- L., S. Martel, and M. Kuschmerick. In vitro preparation of the diaphragm and other skeletal muscles. Methods Enzymol. 39: 82-93, 1975.
11. Goodman, M. N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E727-E730,1991.
12. Goodman, M. N. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205: 182-185, 1994.
13. Hall-Angerås, M., U. Angerås, D. vonAllmen, T. Higashiguchi, O. Zamir, P. O. Hasselgren, and J. E. Fischer. Influence of sepsis in rats on muscle protein turnover in vivo and in tissue incubated under different in vitro conditions. Metabolism 40: 247-251,1991.
14. Hall-Angerås, M., U. Angerås, O. Zamir, P. O. Hasselgren, and J. E. Fischer. Effect of the glucocorticoid receptor antagonist RU38386 on muscle protein breakdown in sepsis. Surgery 109: 468-473, 1991.
15. Hasselgren, P. O. Methods commonly used to study protein metabolism. In: Protein Metabolism in Sepsis, edited by P. O. Hasselgren. Austin, TX: Landes, 1993, p. 10-33.
16. Hasselgren, P. O., M. Hall-Angerås, U. Angerås, D. W. Benson, J. H. James, and J. E. Fischer. Regulation of total and myofibrillar protein breakdown in rat extensor digitorum longus and soleus muscle incubated flaccid and at resting length. Biochem. J. 267:37-44,1990.
17. Hasselgren, P. O., J. H. James, D. W. Benson, M. HallAngerås, D. T. Hiyama, S. Li, and J. E. Fischer. Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation of insulin. Metabolism 38: 634-640,1989.
18. Hobler, S. C., G. Tiao, J. E. Fischer, J. Monaco, and P. O. Hasselgren. The sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R30-R37,1998.
19. Hong, D. H., and N. E. Forsberg. Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures. Mol. Cell. Endocrinol. 108:199-209,1995.
20. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342,1994.
21. May, L. T., R. Neta, L. L. Moldawer, J. S. Kenney, K. Patel, and P. B. Seghai. Antibodies chaperone circulating IL-6: paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo. J. Immunol. 151:3225-3236,1993.
22. Medina, R., S. S. Wing, and A. L. Goldberg. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 307: 631-637,1995.
23. Meyer, T. A., J. Wang, G. Tiao, C. K. Ogle, J. E. Fischer, and P. O. Hasselgren. Sepsis and endotoxemia stimulate intestinal IL-6 production. Surgery 118: 336-342,1995.
24. Mitch, W. E., R. Medina, S. Grieber, R. C. May, B. K. England, S. R. Price, J. L. Bailey, and A. L. Goldberg. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine-triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93: 2127-2133, 1994.
25. Naitoh, Y, J. Fukata, T. Tominaga, Y. Nakia, S. Tamia, K. Mori, and H. Imura. Interleukin-6 stimulates the secretion of adenocorticotropic hormone in conscious freely-moving rats. Biochem. Biophys. Res. Commun. 155:1459-1463,1988.
26. Stouthard, J. M., J. A. Romijn, T. van der Poll, E. Endert, S. Klein, P. J. Bakker, and C. H. Veenhof. Endocrinologie and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E813-E819,1995.
27. Strassman, G., M. Fong, J. S. Kenney, and C. O. Jacob. Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J. Clin. Invest. 89:1681-1684,1992.
28. Tawa, N. E., R. Odessey, and A. L. Goldberg. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:197-203,1997.
29. Temparis, S., M. Asensi, D. Taillandier, E. Aurousseau, D. Larbaud, A. Obled, D. Béchet, M. Ferrara, J. M. Estrela, and D. Attaix. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res. 54: 5568-5573,1994.
30. Tiao, G., J. Fagan, V. Roegner, M. Lieberman, J. J. Wang, J. E. Fischer, and P. O. Hasselgren. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 97:339-348,1996.
31. Tiao, G., J. M. Fagan, N. Samuels, J. H. James, K. Hudson, M. Lieberman, J. E. Fischer, and P. O. Hasselgren. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94:2255-2264,1994.
32. Tiao, G., S. Hobler, J. J. Wang, T. A. Meyer, F. A. Luchette, J. E. Fischer, and P. O. Hasselgren. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J. Clin. Invest. 99: 163-168, 1997.
33. Tiao, G., M. Lieberman, J. E. Fischer, and P. O. Hasselgren. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R849-R856,1997.
34. Tsujinaka, T., C. Ebisui, J. Fujita, M. Kishibuchi, T. Morimoto, A. Ogana, A. Katsume, Y. Ohsugi, E. Kominami, and M. Monden. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 trans-genic mouse. Biochem. Biophys. Res. Commun. 207: 168-174, 1995.
35. Tsujinaka, T., J. Fujita, C. Ebisui, M.Yano, E. Kominami, K. Suzuki, K. Tanaka, A. Katsume, Y. Ohsugi, H. Shiozaki, and M. Monden. Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in fnterleukin-6 transgenic mice. J. Clin. Invest. 97:244-249, 1996.
36. Wang, Q., J. E. Fischer, and P. O. Hasselgren. Treatment of endotoxemic mice with IL-6 antibody paradoxically increases IL-6 levels and stimulates mucosal protein synthesis. Arch. Surg. 132:82-88,1997.
37. Wing, S. S., and A. L. Goldberg. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E668-E676,1993.
38. Zamir, O., P. O. Hasselgren, T. Higashiguchi, J. A. Frederick, and J. E. Fischer. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediat. Inflam. 1:247-250,1992.
39. Zamir, O., P. O. Hasselgren, S. L. Kunkel, J. A. Frederick, T. Higashiguchi, and J. E. Fischer. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127:170-179,1992.
40. Zamir, O., W. O'Brien, R. Thompson, D. C. Bloedow, J. E. Fischer, and P. O. Hasselgren. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int. J. Biochem. 26:943-950,1994.